$VTIX

Meta's Quest launch lifts Virtuix orders about 150%, but sales fell

Virtuix (VTIX) reported Q1 FY2027 results with Omni One orders up 72% YoY and 150% since Meta's Quest launch. Net sales fell 26% to $0.8M, but gross profit rose 29% to $227,158. Net loss widened to $7.2M. The company expanded into defense, enterprise robotics (Tesla's Optimus), NASA missions, and healthcare (Sirica Therapeutics).

Original reporting
Published Aug 19, 2026, 9:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 19, 2026, 11:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$VTIX
Neutral
medium confidence
Mentioned
$VTIX
Relevance
7/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$VTIXNeutralMed
01

Why it matters

Earnings release provides fresh data on order trends, margins, and cash position, informing short‑term trading decisions.

02

Market read

Micro‑cap stock with recent volatility; earnings data may drive near‑term price action.

03

What to watch

Potential future contracts with NASA and Tesla may unlock longer‑term upside.

Relevance 7/10Novelty 8/10Timing: post‑earnings release

Background

Virtuix reported FY2027 Q1 results, noting a 150% jump in Omni One orders after Meta Quest integration.

Company-level read

Ticker impact

$VTIXNeutralMedium confidence
Context

First-quarter FY2027 earnings released with new orders, sales decline and widened loss.

Expected impact

Potential short‑term upside to $1.80 if order momentum continues; downside risk if cash burn accelerates.

Evidence & confidence

Order surge (+150%) is positive, but revenue drop and cash burn may limit upside; market already priced a ~4% move.

Market effects

Highlights growing demand for VR training in defense and enterprise robotics.

U.S. defense and tech sectors may see modest interest.

Limited to niche VR/AR hardware market.

Counterpoint

Cash burn and declining sales could pressure the stock despite order growth.

Key entities

  • Virtuix Holdings Inc.

    NASDAQ‑listed VR training hardware provider.

  • Meta Platforms Inc.

    Collaborated on Omni One for Quest.

Related articles

$VTIXMed

Quarterly revenue beat analyst expectations by more than 50% at Virtuix

Virtuix (VTIX) reported quarterly revenue exceeding analyst expectations by over 50%, driven by strong consumer demand for its Omni One platform. The company will present at the H.C. Wainwright conference, highlighting expansions into defense, robotics, healthcare, and enterprise markets, including partnerships with Tesla and the U.S. Marine Corps. VTIX stock declined 9.52% on the news.

$VTIXMed

Research firm sees 644% potential upside for Virtuix; orders rose 72% after Meta partnership

Emerging Growth Research reaffirmed its Buy-Emerging rating and $9.00 price target for Virtuix (VTIX), implying 644% upside. Q1 2027 revenue was $0.8M, down 26% YoY but above estimates, driven by a 72% rise in new orders post-Meta partnership. Gross margin expanded to 30%, and EPS improved sequentially to $(0.22). The firm projects 19% and 275% revenue growth for fiscal 2027 and 2028, respectively, but notes execution and financing risks.

$VTIXMed

Virtuix Holdings Inc. (VTIX): Results of Operations and Financial Condition

Virtuix Holdings Inc. (VTIX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Virtuix Reports First Quarter Fiscal Year 2027 Results as Omni One Orders Increase 150% Following Meta Launch Orders Increased 72% Year-over-Year and Approximately 150% Since the Launch of Omni One for Quest as Meta Launch Drives Accelerating Consumer Demand Gross Pr

$VTIXHigh

Virtuix Q1 sales $767K, EPS ($0.22) beat estimates

Virtuix (VTIX) reported Q1 FY2027 net sales of $767K, beating estimates, with a net loss per share of ($0.22). Gross profit rose 29% to $227K, driven by higher selling prices. Operating expenses increased 86% to $4.1M. The company secured its first Omni One Enterprise sale to Tesla. Cash reserves stood at $7.4M. The earnings release and conference call were rescheduled to August 19-20, 2026, due to a new audit firm's review.

$VTIXMed

Virtuix Reports 72% Year-over-Year Order Growth, Margin Expansion, and New Defense, Enterprise, and Healthcare Wins in Fiscal Q1 2027

Virtuix reported a 72% year-over-year increase in orders and a 29% rise in gross profit for Q1 2027. Gross margin expanded to 30% from 17%. The company secured new defense, enterprise, and healthcare contracts, including deals with Tesla, NASA, and the U.S. Marine Corps. Net sales were $0.8 million, down 26% year-over-year, but orders surged.